These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20829439)

  • 1. Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice.
    Singh S; Vinson C; Gurley CM; Nolen GT; Beggs ML; Nagarajan R; Wagner EF; Parham DM; Peterson CA
    Am J Pathol; 2010 Oct; 177(4):2055-66. PubMed ID: 20829439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma.
    Bois PR; Izeradjene K; Houghton PJ; Cleveland JL; Houghton JA; Grosveld GC
    J Cell Biol; 2005 Sep; 170(6):903-12. PubMed ID: 16157701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
    Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
    Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The over-expression of cell migratory genes in alveolar rhabdomyosarcoma could contribute to metastatic spread.
    Rapa E; Hill SK; Morten KJ; Potter M; Mitchell C
    Clin Exp Metastasis; 2012 Jun; 29(5):419-29. PubMed ID: 22415709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.
    Chen EY; DeRan MT; Ignatius MS; Grandinetti KB; Clagg R; McCarthy KM; Lobbardi RM; Brockmann J; Keller C; Wu X; Langenau DM
    Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5349-54. PubMed ID: 24706870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EHMT2 epigenetically suppresses Wnt signaling and is a potential target in embryonal rhabdomyosarcoma.
    Pal A; Leung JY; Ang GCK; Rao VK; Pignata L; Lim HJ; Hebrard M; Chang KT; Lee VK; Guccione E; Taneja R
    Elife; 2020 Nov; 9():. PubMed ID: 33252038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells.
    Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L
    PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.
    Annavarapu SR; Cialfi S; Dominici C; Kokai GK; Uccini S; Ceccarelli S; McDowell HP; Helliwell TR
    Lab Invest; 2013 Oct; 93(10):1090-9. PubMed ID: 23999248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness.
    Chiappalupi S; Riuzzi F; Fulle S; Donato R; Sorci G
    Carcinogenesis; 2014 Oct; 35(10):2382-92. PubMed ID: 25123133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target.
    Mercado GE; Xia SJ; Zhang C; Ahn EH; Gustafson DM; Laé M; Ladanyi M; Barr FG
    Genes Chromosomes Cancer; 2008 Jun; 47(6):510-20. PubMed ID: 18335505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide production upregulates Wnt/β-catenin signaling by inhibiting Dickkopf-1.
    Du Q; Zhang X; Liu Q; Zhang X; Bartels CE; Geller DA
    Cancer Res; 2013 Nov; 73(21):6526-37. PubMed ID: 24008318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
    Belyea BC; Naini S; Bentley RC; Linardic CM
    Clin Cancer Res; 2011 Dec; 17(23):7324-36. PubMed ID: 21948088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.
    Kim MS; Yoon SK; Bollig F; Kitagaki J; Hur W; Whye NJ; Wu YP; Rivera MN; Park JY; Kim HS; Malik K; Bell DW; Englert C; Perantoni AO; Lee SB
    J Biol Chem; 2010 May; 285(19):14585-93. PubMed ID: 20220130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
    Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C
    Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dysfunctional miR-1-TRPS1-MYOG axis drives ERMS by suppressing terminal myogenic differentiation.
    Hüttner SS; Henze H; Elster D; Koch P; Anderer U; von Eyss B; von Maltzahn J
    Mol Ther; 2023 Sep; 31(9):2612-2632. PubMed ID: 37452493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling in triple negative breast cancer is associated with metastasis.
    Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
    BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix stiffness dictates Wnt expression through integrin pathway.
    Du J; Zu Y; Li J; Du S; Xu Y; Zhang L; Jiang L; Wang Z; Chien S; Yang C
    Sci Rep; 2016 Feb; 6():20395. PubMed ID: 26854061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.
    Ueno K; Hirata H; Majid S; Chen Y; Zaman MS; Tabatabai ZL; Hinoda Y; Dahiya R
    Mol Carcinog; 2011 Jun; 50(6):449-57. PubMed ID: 21268126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.